Invention Grant
- Patent Title: Reversibly blocked nucleoside analogues and their use
-
Application No.: US16094845Application Date: 2017-04-21
-
Publication No.: US10988501B2Publication Date: 2021-04-27
- Inventor: Handong Li , Snezana Drmanac , Radoje Drmanac , Xun Xu , Lingling Peng , Scott Gablenz
- Applicant: Complete Genomics, Inc. , BGI Shenzhen
- Applicant Address: US CA San Jose; CN Shenzhen
- Assignee: Complete Genomics, Inc.,BGI Shenzhen
- Current Assignee: Complete Genomics, Inc.,BGI Shenzhen
- Current Assignee Address: US CA San Jose; CN Shenzhen
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US2017/028930 WO 20170421
- International Announcement: WO2017/185026 WO 20171026
- Main IPC: C07H19/10
- IPC: C07H19/10 ; C07H19/20 ; C07H15/04 ; C12Q1/6869 ; C07H21/04
Abstract:
Reversibly blocked nucleoside analogues and methods of using such nucleoside analogues for sequencing of nucleic acids are provided.
Public/Granted literature
- US20190144482A1 Reversibly Blocked Nucleoside Analogues And Their Use Public/Granted day:2019-05-16
Information query
IPC分类:
